1
|
Cao X, Zeng J, Ou Y, Chen J, Lyu J, Zhou Q. A prognostic nomogram for the cancer-specific survival rate of choroidal melanoma using the Surveillance, Epidemiology, and End Results database. Front Med (Lausanne) 2024; 11:1392336. [PMID: 38818391 PMCID: PMC11137212 DOI: 10.3389/fmed.2024.1392336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2024] [Accepted: 05/02/2024] [Indexed: 06/01/2024] Open
Abstract
Objective This study was conducted to develop a comprehensive nomogram for individuals with choroidal melanoma (CM) to determine their cancer-specific survival (CSS). Methods Data of individuals with CM, diagnosed between 2004 and 2015, were accessed at the Surveillance, Epidemiology, and End Results (SEER) database. The selected individuals were randomly categorized into a training and validation cohort. Multivariate Cox regression analysis was applied to screen the relevant variables. Followed by the development of a nomogram based on independent variables. Ultimately, the net reclassification index (NRI), concordance index (C-index), calibration charts, integrated discrimination improvement (IDI), receiver operating characteristic curves (ROC), area under the curve (AUC), and decision-curve analysis (DCA), were utilized to evaluate the discrimination, accuracy, and effectiveness of the model. Results This study enrolled 3,782 patients. Seven independent factors linked to prognosis were screened via multivariate Cox regression analysis, encompassing age at diagnosis; race; AJCC (American Joint Committee on Cancer) stage; histologic type; and therapy method of radiotherapy, surgery, and chemotherapy. The respective C-indexes of the training and validation cohorts were 0.709 and 0.726, indicative of the excellent accuracy of the nomogram. Furthermore, the AUCs of the training and validation cohorts across 3, 5, and 8 years were 0.767, 0.744, and 0.722 as well as 0.772, 0.770, and 0.753, respectively. Evident of the superiority of the established nomogram over the AJCC staging, both the NRI and IDI values exhibited improvement. The favorable clinical impact and good performance of the nomogram were evident via decision curve analyses (DCAs) and calibration plots, respectively. Conclusion This research dealt with establishing and validating a nomogram as a prognostic tool for assessing the prognosis of adult patients with CM utilizing the SEER database. A comprehensive assessment of the nomogram via diverse variables demonstrated its accuracy in predicting the CSS probabilities of CM patients across 3, 5, and 8 years in clinical settings. Notably, its performance surpassed that of the AJCC staging system.
Collapse
Affiliation(s)
- Xianfen Cao
- Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, China
- Department of Ophthalmology, The First People’s Hospital of Chenzhou, Chenzhou, China
| | - Jing Zeng
- Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, China
- Ophthalmic Center, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
| | - Yulun Ou
- Department of Ophthalmology, The First People’s Hospital of Chenzhou, Chenzhou, China
| | - Jian Chen
- Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, China
| | - Jun Lyu
- Department of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, China
| | - Qing Zhou
- Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, China
| |
Collapse
|
2
|
Bai H, Bosch JJ, Heindl LM. Current management of uveal melanoma: A review. Clin Exp Ophthalmol 2023. [PMID: 37076276 DOI: 10.1111/ceo.14214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Revised: 02/12/2023] [Accepted: 02/13/2023] [Indexed: 04/21/2023]
Abstract
Uveal melanoma is the most frequent primary intraocular cancer in adulthood and is mostly localised to the choroid. It can be treated using radiation therapy, laser therapy, local resection and enucleation, with the best results achieved by combining these procedures. However, up to half of patients develop metastatic disease. There are no efficacious treatment methods for patients in advanced stage or with metastasis. In recent years, several novel treatment modalities aimed at improving tumour control and reducing adverse events have emerged. This review summarises current clinical treatment methods and new therapeutic perspectives for uveal melanoma.
Collapse
Affiliation(s)
- Haixia Bai
- Eye Center, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
| | - Jacobus J Bosch
- Centre for Human Drug Research, Leiden, Netherlands
- Leiden University Medical Center, Leiden, Netherlands
| | - Ludwig M Heindl
- Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany
- Center for Integrated Oncology (CIO) Aachen-Bonn-Cologne-Duesseldorf, Cologne, Germany
| |
Collapse
|
3
|
Baba S, Akiyama Y, Endo F, Nikai H, Sugimoto R, Umemura A, Katagiri H, Hasegawa Y, Iwaya T, Nitta H, Koeda K, Sugai T, Sasaki A. Laparoscopic distal pancreatectomy for metastatic melanoma originating from the choroidal membrane: a case report. Surg Case Rep 2021; 7:268. [PMID: 34928463 PMCID: PMC8688594 DOI: 10.1186/s40792-021-01345-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2021] [Accepted: 12/06/2021] [Indexed: 11/17/2022] Open
Abstract
Background Metastatic melanoma originating from the choroidal membrane is extremely rare. Here, we report a case of laparoscopic distal pancreatectomy for malignant melanoma that developed after heavy-particle therapy for malignant choroidal melanoma. Case presentation A 43-year-old Japanese woman underwent 70 Gy heavy-particle radiotherapy for a right choroidal malignant melanoma. Positron emission tomography-computed tomography examination was performed 4 years after treatment, when contrast accumulation was observed on the posterior wall of the stomach. Endoscopic ultrasonography and computed tomography showed a mass with contrast enhancement in contact with the stomach wall. Based on the imaging findings, a gastrointestinal stromal tumor of the posterior wall of the lower gastric corpus with extramural growth was suspected. Laparoscopic surgery was performed under general anesthesia. A black-pigmented tumor originating from the pancreas was discovered. Following an intraoperative diagnosis of metastasis of malignant melanoma, a laparoscopic distal pancreatectomy was performed. The pathological diagnosis was pancreatic metastasis of malignant melanoma. The patient was treated with adjuvant immune checkpoint inhibitors and chemotherapy after surgery, which led to long-term survival. Conclusions Including this case, only eight case reports on pancreatic resection for metastatic ocular malignant melanoma have been reported. The ocular malignant melanoma with distant metastasis has a poor prognosis. Therefore, in our case, careful follow-up is required. A single pancreatic metastasis from a malignant melanoma of the choroid can be successfully managed by laparoscopic radical resection of the pancreas, and molecularly targeted adjuvant chemotherapy.
Collapse
|
4
|
Toro MD, Gozzo L, Tracia L, Cicciù M, Drago F, Bucolo C, Avitabile T, Rejdak R, Nowomiejska K, Zweifel S, Yousef YA, Nazzal R, Romano GL. New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review. Biomedicines 2021; 9:biomedicines9101311. [PMID: 34680428 PMCID: PMC8533164 DOI: 10.3390/biomedicines9101311] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 09/15/2021] [Accepted: 09/21/2021] [Indexed: 12/13/2022] Open
Abstract
Uveal melanoma (UM) is a rare disease, but the most common primary intraocular cancer, mostly localized in the choroid. Currently, the first-line treatment options for UM are radiation therapy, resection, and enucleation. However, although these treatments could potentially be curative, half of all patients will develop metastatic disease, whose prognosis is still poor. Indeed, effective therapeutic options for patients with advanced or metastatic disease are still lacking. Recently, the development of new treatment modalities with a lower incidence of adverse events, a better disease control rate, and new therapeutic approaches, have merged as new potential and promising therapeutic strategies. Additionally, several clinical trials are ongoing to find new therapeutic options, mainly for those with metastatic disease. Many interventions are still in the preliminary phases of clinical development, being investigated in phase I trial or phase I/II. The success of these trials could be crucial for changing the prognosis of patients with advanced/metastatic UM. In this systematic review, we analyzed all emerging and available literature on the new perspectives in the treatment of UM and patient outcomes; furthermore, their current limitations and more common adverse events are summarized.
Collapse
Affiliation(s)
- Mario Damiano Toro
- Department of Ophthalmology, University of Zurich, 8091 Zurich, Switzerland; (M.D.T.); (S.Z.)
- Department of General and Pediatric Ophthalmology, Medical University of Lublin, 20079 Lublin, Poland; (R.R.); (K.N.)
| | - Lucia Gozzo
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy; (F.D.); (C.B.); (G.L.R.)
- Clinical Pharmacology Unit, Regional Pharmacovigilance Centre, University Hospital of Catania, 95123 Catania, Italy
- Correspondence: ; Tel.: +39-095-3781757
| | - Luciano Tracia
- Plastic and Reconstructive Surgery Department, American Hospital Dubai, Dubai, United Arab Emirates;
| | - Marco Cicciù
- Department of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, AOU ‘G. Martino’, 98124 Messina, Italy;
| | - Filippo Drago
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy; (F.D.); (C.B.); (G.L.R.)
- Clinical Pharmacology Unit, Regional Pharmacovigilance Centre, University Hospital of Catania, 95123 Catania, Italy
- Centre for Research and Consultancy in HTA and Drug Regulatory Affairs (CERD), University of Catania, 95123 Catania, Italy
| | - Claudio Bucolo
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy; (F.D.); (C.B.); (G.L.R.)
- Center of Research in Ocular Pharmacology—CERFO, University of Catania, 95123 Catania, Italy
| | - Teresio Avitabile
- Department of Ophthalmology, University of Catania, 95123 Catania, Italy;
| | - Robert Rejdak
- Department of General and Pediatric Ophthalmology, Medical University of Lublin, 20079 Lublin, Poland; (R.R.); (K.N.)
| | - Katarzyna Nowomiejska
- Department of General and Pediatric Ophthalmology, Medical University of Lublin, 20079 Lublin, Poland; (R.R.); (K.N.)
| | - Sandrine Zweifel
- Department of Ophthalmology, University of Zurich, 8091 Zurich, Switzerland; (M.D.T.); (S.Z.)
| | - Yacoub A. Yousef
- Department of Surgery/Ophthalmology, King Hussein Cancer Center, Amman 11941, Jordan;
| | | | - Giovanni Luca Romano
- Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy; (F.D.); (C.B.); (G.L.R.)
- Center of Research in Ocular Pharmacology—CERFO, University of Catania, 95123 Catania, Italy
| |
Collapse
|
5
|
Menon V, Thulasidas M, Narula R, Mulay K, Honavar SG. Multicentric recurrent uveal melanoma. Indian J Ophthalmol 2020; 68:2305-2307. [PMID: 32971703 PMCID: PMC7727941 DOI: 10.4103/ijo.ijo_511_20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2020] [Revised: 04/04/2020] [Accepted: 05/06/2020] [Indexed: 11/30/2022] Open
Abstract
Uveal melanoma is a rare malignancy originating from melanocytes within the uveal tract of the eye. True multifocal uveal melanomas (>2melanomas in 1 eye) occurring in the same eye are very rare. We report a clinically and histologically well-documented case of a patient who presented with 3 uveal melanoma lesions in the same eye over a span of 2.5 years. The eye had to be enucleated finally and diagnosis confirmed histologically. This case report highlights the need for a close follow-up, even after successful treatment of the presenting lesion in uveal melanomas.
Collapse
Affiliation(s)
- Vikas Menon
- Ophthalmic Plastic Surgery and Ocular Oncology Services, Centre for Sight, New Delhi, India
| | - Mithun Thulasidas
- Ophthalmic Plastic Surgery and Ocular Oncology Services, Centre for Sight, New Delhi, India
| | - Ritesh Narula
- Vitreo-Retina Services, Centre for Sight, New Delhi, India
| | - Kautubh Mulay
- Ophthalmic Plastic Surgery, Ocular Oncology and Ocular Pathology Services, Centre for Sight, Hyderabad, Telangana, India
| | - Santosh G Honavar
- Ophthalmic Plastic Surgery, Ocular Oncology and Ocular Pathology Services, Centre for Sight, Hyderabad, Telangana, India
| |
Collapse
|
6
|
Grech A, Mercieca N, Calleja-Agius J, Abela R. Metastatic malignant melanoma of unknown primary in temporalis muscle. J Surg Case Rep 2020; 2020:rjaa202. [PMID: 32665835 PMCID: PMC7332289 DOI: 10.1093/jscr/rjaa202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2020] [Accepted: 05/29/2020] [Indexed: 11/29/2022] Open
Abstract
Metastatic melanoma of unknown primary (MUP) is an uncommon melanocytic lesion found in distant sites with no evident skin involvement. This case report presents a 75-year-old woman who underwent local excision for a lump in the right temporal area, which had been present for 6 months and had been suspected to be a lipoma. Histology confirmed that the tissue excised from the temporalis muscle was composed of atypical, heavily pigmented melanocytes. Her history was negative for melanocytic lesions, and examination and extensive investigation including imaging had failed to identify a primary lesion. The patient is currently being followed up.
Collapse
Affiliation(s)
- Alexia Grech
- The Foundation Programme Malta, Mater Dei Hospital, Msida, Malta
| | | | - Jean Calleja-Agius
- Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
| | - Rachel Abela
- Department of Surgery, Gozo General Hospital, Victoria, Gozo, Malta
| |
Collapse
|
7
|
Ye Z, Yang Z, Zheng S, Wang W. Robot-assisted laparoscopic surgery for abdominal metastatic melanoma mimicking a gastrointestinal stromal tumor: A case report and review of the literature. Medicine (Baltimore) 2018; 97:e11207. [PMID: 29952974 PMCID: PMC6039597 DOI: 10.1097/md.0000000000011207] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
RATIONALE Uveal melanoma is the most common primary intraocular malignancy, which could metastasize at an early stage of the disease and associated with poor prognoses. Liver, small bowel, stomach, and colon are the most common locations for metastatic visceral melanoma, however, solitary abdominal metastasis from uveal melanoma is extremely rare. PATIENT CONCERNS The current study reports the case of a 33-year-old man with history of treated choroidal melanoma of the left eye that developed metastasis to the abdomen, preoperative endoscopic ultrasonography and computed tomography strongly suggested as a gastrointestinal stromal tumor (GIST). DIAGNOSES The patient was diagnosed with abdominal metastatic melanoma according to his medical history and histopathological results. INTERVENTIONS The young adult underwent robot-assisted laparoscopic surgery. OUTCOMES The patient finally got the definite diagnosis with his medical history and histopathological results and he has been living disease free for nearly 3 years after the surgery. LESSONS Although rare, the possibility of abdominal metastatic melanoma presenting with the clinical picture of gastrointestinal stromal tumor must be always considered by the surgeon especially the patients with a history of primary malignant melanoma.
Collapse
Affiliation(s)
- Zhou Ye
- Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine
| | - Zhe Yang
- Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine
| | - Shusen Zheng
- Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine
- Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou, Zhejiang Province, PR China
| | - Weilin Wang
- Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine
- Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou, Zhejiang Province, PR China
| |
Collapse
|
8
|
Mahajan D, Gupta RK, Chaudhary KP. A rare case of superior hypopyon with iris neovascularization. Oman J Ophthalmol 2018; 11:97-99. [PMID: 29563712 PMCID: PMC5848365 DOI: 10.4103/0974-620x.226351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Affiliation(s)
- Deepti Mahajan
- Department of Ophthalmology, I.G.M.C., Shimla, Himachal Pradesh, India,Address for correspondence: Dr. Deepti Mahajan, Arunodaya, Cemetery Road, Sanjauli, Shimla - 171 006 Himachal Pradesh, India. E-mail:
| | | | | |
Collapse
|
9
|
Jaradat I, Zewar A, AlNawaiseh I, AlRawashdeh K, Khurma S, Mehyar M, Abdeen G, Yousef YA. Characteristics, management, and outcome of patients with uveal melanoma treated by Iodine-125 radioactive plaque therapy in a single tertiary cancer center in Jordan. Saudi J Ophthalmol 2017; 32:130-133. [PMID: 29942182 PMCID: PMC6010601 DOI: 10.1016/j.sjopt.2017.12.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2017] [Revised: 11/13/2017] [Accepted: 12/19/2017] [Indexed: 02/03/2023] Open
Abstract
Objective To evaluate King Hussein Cancer Center experience in using Iodine-125 COMS radioactive plaque for treatment of Uveal Melanoma in Jordan. Methods Retrospective case series of eyes with uveal melanoma treated by Iodine-125 COMS radioactive plaque therapy. Data collection required access to medical, radiology, Labs and pathology reports. Main outcomes studied includes: Demographics, tumor features, eye salvage, visual outcome, metastasis, and mortality. Results Between September 2008 and March 2015, 28 eyes for 28 patients had intraocular uveal melanoma and treated by Iodine-125 radioactive plaque therapy. The mean age at diagnosis was 48 years and 16(57%) were males. The mean tumor thickness was 8 mm (range: 4–13 mm), and 27(96%) patients had medium or large size tumor. The radioactive plaques used had a median size of 16 mm (range: 12–20 mm). The mean apical dose was 83.5 Gy (range 81–87 Gy), and the median radiation rate was 7.25 (range: 4.5–13). At median follow up of 2 years (range 0.5–7 years), eye salvage rate was 93%. Four (15%) patients had distance metastasis, and 3(11%) were dead. Fifty percent of patient had visual acuity better than 20/200 at the last date of follow up. Conclusion Our preliminary results are encouraging and are comparable to another countries worldwide. The use of Iodine-125 COMs plaque therapy at the inspection of implementation of plaque therapy in the developing countries can lead to eye salvage in more than 90% of cases, and reserves functional vision in more than 50% of cases.
Collapse
Affiliation(s)
- Imad Jaradat
- Department of Radiation Oncology, King Hussein Cancer Centre (KHCC), Amman, Jordan
| | - Ahmed Zewar
- Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman, Jordan
| | - Ibrahim AlNawaiseh
- Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman, Jordan
| | - Khaleel AlRawashdeh
- Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman, Jordan
| | - Samer Khurma
- Department of Radiation Oncology, King Hussein Cancer Centre (KHCC), Amman, Jordan
| | - Mustafa Mehyar
- Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman, Jordan
| | - Ghadeer Abdeen
- Department of Medical Oncolgoy, King Hussein Cancer Centre (KHCC), Amman, Jordan
| | - Yacoub A Yousef
- Department of Surgery (Ophthalmology), King Hussein Cancer Centre (KHCC), Amman, Jordan
| |
Collapse
|
10
|
Dalle Carbonare M, Goh MX, AlshiekhAli Z, Howlett D. Metastatic melanoma of unknown primary in the temporalis muscle. BMJ Case Rep 2017; 2017:bcr-2017-221577. [PMID: 29054896 DOI: 10.1136/bcr-2017-221577] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Melanomas are aggressive cancers that present as cutaneous, mucosal and ocular lesions with the ability to metastasise widely. There are, however, occasions where lesions are found in distant sites such as lymph nodes, viscera and subcutaneous tissues without clinically apparent skin involvement. This is known as metastatic melanoma of unknown primary (MUP). Its presentation in skeletal muscle is rare, and the available literature is sparse. This article presents an 85-year-old woman with a MUP presenting in the right temporalis muscle, which was diagnosed with the aid of the ultrasound-guided core biopsy. The melanoma deposit was successfully excised, and no recurrence was identified. The patient is now under close follow-up.
Collapse
Affiliation(s)
- Marco Dalle Carbonare
- Oral and Maxillofacial Surgery Department, Eastbourne District General Hospital, Eastbourne, UK
| | - Mei Xien Goh
- Oral and Maxillofacial Surgery Department, Eastbourne District General Hospital, Eastbourne, UK
| | - Zainab AlshiekhAli
- Pathology Department, Eastbourne District General Hospital, Eastbourne, UK
| | - David Howlett
- Radiology Department, Eastbourne District General Hospital, Eastbourne, UK
| |
Collapse
|
11
|
Zwetyenga N, Hallier A, Girodon M, Levasseur J, Loison-Robert L, Moris V. Isolated unilateral temporalis muscle hypertrophy: First case in an 8-year-old boy and review. JOURNAL OF STOMATOLOGY, ORAL AND MAXILLOFACIAL SURGERY 2017; 119:61-66. [PMID: 29030277 DOI: 10.1016/j.jormas.2017.10.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/02/2016] [Revised: 08/16/2017] [Accepted: 10/02/2017] [Indexed: 11/18/2022]
Abstract
INTRODUCTION Isolated unilateral temporalis muscle hypertrophy (IUTMH) was first described in 1990 and few cases have been published since then. This disease occurs mainly in adults. There is no clear etiology of IUTMH, but bruxism is one of the risk factors. Only two cases have been described before the age of 20 years. To our knowledge, no cases have been described in persons younger than 15 years old. We report the first case of IUTMH in an 8-year-old and review the literature. MATERIAL AND METHODS This section is separated into 3 parts: (1) search for and description of clinical cases of IUTMH in our department; (2) literature search to find similar cases; (3) data analysis of all cases found. RESULTS Ten patients, including our case, were found over a period of 23 years: five females and five males with a mean age of 32.8 years. One patient was 15 years old. Time between onset and diagnosis was 16.7 months. Half of the patients reported pain and three had experienced bruxism. Most of the patients had non-surgical treatment. One patient evolved favorably with no treatment. One recurrence occurred 10 years later. DISCUSSION IUTMH can occur in childhood in a high-stress environment. Diagnosis is based on the history and clinical and imaging findings. Biopsy helps to confirm the diagnosis, but electromyograms and neurological tests contribute little. Bruxism should be taken into account. The treatment with the least inconvenience must be given.
Collapse
Affiliation(s)
- N Zwetyenga
- Department of Oral and Maxillofacial Surgery, Department of Plastic Reconstructive and Hand Surgery, centre hospitalier universitaire, CHU de Dijon, boulevard de Lattre-de-Tassigny, 21000 Dijon, France; University of Bourgogne Franche-Comté, Lipids Nutrition Cancer team NuTox UMR866, boulevard Jeanne-d'Arc, 21000 Dijon, France.
| | - A Hallier
- Department of Oral and Maxillofacial Surgery, Department of Plastic Reconstructive and Hand Surgery, centre hospitalier universitaire, CHU de Dijon, boulevard de Lattre-de-Tassigny, 21000 Dijon, France
| | - M Girodon
- Department of Oral and Maxillofacial Surgery, Department of Plastic Reconstructive and Hand Surgery, centre hospitalier universitaire, CHU de Dijon, boulevard de Lattre-de-Tassigny, 21000 Dijon, France
| | - J Levasseur
- Department of Oral and Maxillofacial Surgery, Department of Plastic Reconstructive and Hand Surgery, centre hospitalier universitaire, CHU de Dijon, boulevard de Lattre-de-Tassigny, 21000 Dijon, France
| | - L Loison-Robert
- Department of Oral Medicine and Dental Surgery, boulevard de Lattre-de-Tassigny, 21000 Dijon, France
| | - V Moris
- Department of Oral and Maxillofacial Surgery, Department of Plastic Reconstructive and Hand Surgery, centre hospitalier universitaire, CHU de Dijon, boulevard de Lattre-de-Tassigny, 21000 Dijon, France
| |
Collapse
|
12
|
Costache M, Patrascu OM, Adrian D, Costache D, Sajin M, Ungureanu E, Simionescu O. Ciliary body melanoma - a particularly rare type of ocular tumor. Case report and general considerations. MAEDICA 2013; 8:360-364. [PMID: 24790669 PMCID: PMC3968473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/27/2013] [Accepted: 12/06/2013] [Indexed: 06/03/2023]
Abstract
Uveal melanoma is the most common primary malignancy of the eye in white adults. Frequently, uveal melanoma arises from choroid or iris. Ciliary body melanoma is a rare if not exceptional subtype of uveal melanoma. Furthermore, ciliary melanoma is often seen in association with the other two subtypes of uveal melanoma. This paper presents a case of primary ciliary melanoma with invasion of the iris. The patient presented with blurred vision, but this symptom could not doubtless be related with the existence of the tumor, because of the small dimension of the malignancy and the lack of medical history of the patient.This tumor was included in the category of "very small ciliary melanoma", a rare diagnosis considering the fast local invasion and the lack of symptoms in such a small tumor. Histopathological and imunohistochemical examinations confirmed the diagnosis of ciliary melanomaThis type of ocular melanoma has a low prognosis due to early metastases.
Collapse
Affiliation(s)
- Mariana Costache
- Department of Pathology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
| | | | - Dumitru Adrian
- Department of Pathology, Emergency University Hospital, Bucharest, Romania
| | - Diana Costache
- "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
| | - Maria Sajin
- Department of Pathology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
| | - Emil Ungureanu
- Department of Ophthalmology, Emergency University Hospital Bucharest, Romani
| | - Olga Simionescu
- Department of Dermatology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
| |
Collapse
|
13
|
Katsetos CD, Bianchi MA, Jaffery F, Koutzaki S, Zarella M, Slater R. Painful unilateral temporalis muscle enlargement: reactive masticatory muscle hypertrophy. Head Neck Pathol 2013; 8:187-93. [PMID: 23900775 PMCID: PMC4022940 DOI: 10.1007/s12105-013-0480-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/27/2013] [Accepted: 07/19/2013] [Indexed: 12/01/2022]
Abstract
An instance of isolated unilateral temporalis muscle hypertrophy (reactive masticatory muscle hypertrophy with fiber type 1 predominance) confirmed by muscle biopsy with histochemical fiber typing and image analysis in a 62 year-old man is reported. The patient presented with bruxism and a painful swelling of the temple. Absence of asymmetry or other abnormalities of the craniofacial skeleton was confirmed by magnetic resonance imaging and cephalometric analyses. The patient achieved symptomatic improvement only after undergoing botulinum toxin injections. Muscle biopsy is key in the diagnosis of reactive masticatory muscle hypertrophy and its distinction from masticatory muscle myopathy (hypertrophic branchial myopathy) and other non-reactive causes of painful asymmetric temporalis muscle enlargement.
Collapse
Affiliation(s)
- Christos D. Katsetos
- Department of Pediatrics, Drexel University College of Medicine, Section of Neurology, St. Christopher’s Hospital for Children, Philadelphia, PA 19134 USA ,Department of Pathology and Laboratory Medicine, Drexel University College of Medicine, Philadelphia, PA USA
| | - Michael A. Bianchi
- Division of Oral and Maxillofacial Surgery, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA USA
| | - Fizza Jaffery
- Division of Oral and Maxillofacial Surgery, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA USA
| | - Sirma Koutzaki
- Department of Pathology and Laboratory Medicine, Drexel University College of Medicine, Philadelphia, PA USA
| | - Mark Zarella
- Department of Pathology and Laboratory Medicine, Drexel University College of Medicine, Philadelphia, PA USA
| | | |
Collapse
|
14
|
Elabjer BK, Miletić D, Bušić M, Sarić B, Petrović Z, Bradetić T, Bosnar D. Early satellite metastatic uveal melanoma to the lower eyelid--the first report. Orbit 2011; 31:27-9. [PMID: 22007917 DOI: 10.3109/01676830.2011.605508] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
PURPOSE To present a unique case of an early satellite metastatic uveal melanoma to the ipsilateral lower eyelid. METHODS Retrospective review of the medical records of a single patient. RESULTS A 71-year-old white male developed a fast growing, painless, solitary, subcutaneous, nodular mass in the medial half of his right lower eyelid 13 months after enucleation of the right eye for inferonasally located uveal melanoma of the spindle cell type. Microscopically excised eyelid tumor proved to be malignant melanoma of the epitheloid type. The patient underwent complete systemic examination including positron emission tomography that ruled out the primary cutaneous or visceral melanoma. CONCLUSION The paper is, according to our knowledge, the first documented case of an early satellite metastatic uveal melanoma to the lower eyelid in the patient with no evidence of further metastases.
Collapse
|